Developmental Dysarthria

Pure dysarthria, isolated facial paresis, or dysarthria-facial paresis syndrome.

BACKGROUND AND PURPOSE Pure dysarthria, isolated supranuclear facial paresis, and their combination without somatic motor dysfunction are rarely encountered clinical syndromes and have not yet been clearly characterized. METHODS Thirteen patients (9 men, 4 women; aged 33 to 72 [mean, 56] years) with unilateral strokes who developed dysarthria with or without facial paresis but without somatic...

Developmental dysarthria in a young adult with cerebral palsy: A speech subsystems analysis

The speech of children with cerebral palsy (CP) and dysarthria is associated with limited breath control, voice quality changes and imprecise articulation. These problems can reduce speech intelligibility, which can act as a barrier to successful interactions. Whilst the impact of the speech problems is well recognised, research on the nature of the speech impairment is relatively limited. This...

Irinotecan-Induced Dysarthria

Colorectal carcinomas are among the most common tumor types and are generally treated with palliative chemotherapy in case of metastatic disease. Here, we describe the case of a 46-year-old patient with metastatic rectal carcinoma who received second-line therapy with irinotecan and developed isolated transient dysarthria (with normal MR imaging of the brain) following each administration of ir...

Extending Dysarthria Research

Suboptimal Classifier for Dysarthria Assessment

This work is focused on the design and evaluation of a suboptimal classifier for dysarthria assessment. The classification relied on self organizing maps to discriminate 8 types of dysarthria and a normal group. The classification technique provided an excellent accuracy for assessment and enabled clinicians with a powerful relevance analysis of the input features. This technique also allows a ...